173
Views
8
CrossRef citations to date
0
Altmetric
Commentary

Aspartame Bioassay Findings Portend Human Cancer Hazards

Pages 446-448 | Published online: 19 Jul 2013

References

  • Soffritti M, Belpoggi F, Tibaldi E, Esposito DD, Lauriola M. Lifespan exposure to low doses of aspartame beginning during prenatal life increases cancer effects in rats. Environ Health Perspect 2007; 115: 1293–7.
  • Soffritti M, Belpoggi F, Degli Esposti D, Lambertini L, Tibaldi E,Rigano A. First experimental demonstration of the multipoten-dal carcinogenic effects of aspartame administered in the feed to Sprague-Dawley rats. Environ Health Perspect. 2006; 114: 379–85.
  • Belpoggi F, Soffritti M, Padovani M, Degli Esposti D, Lauriola M, Minardi F. Results of long-term carcinogenicity bioassay on Sprague-Dawley rats exposed to aspartame administered in feed. Ann NYAcad Sci. 2006; 1076: 559–77.
  • FDA Statement on European Aspartame Study, Center for Food Safety and Applied Nutrition, April 20, 2007. http://www.cfsan.fda.gov/ard/fpaspar2.html.
  • Galore Control Council. Overwhelming scientific evidence con-firms safety of aspartame. FDA, others affirm safety of aspartame, 2007. !http://www.aspartame.org/documents/ram07.doc.
  • Huff J. Value, validity, and historical development of carcino-genesis studies for predicting and confirming carc in ogenic risks to humans. Chapter 2: 21-123. In: Kitchin KT (ed). Carcino-genicity Testing, Predicting, 8c Interpreting Chemical Effects. New York: Marcel Dekker, 1999.
  • Soffritti M, Belpoggi F, Minardi F, Maltoni C. Ramazzini Foun-dation cancer program: history and major projects, life-span carcinogenicity bioassay design, chemicals studied, and results. Ann NYAcad Sci. 2002; 982: 26–45.
  • Tomatis L Identification of carcinogenic agents and primary prevention of cancer. Ann NYAcad Sci. 2006; 1076: 1–14.
  • Tomatis L, HuffJ. Evolution of cancer etiology and primary pre-vention. Environ Health Perspect. 2001; 109: A458–60.
  • Rall DP. Laboratory animal tests and human cancer. Drug Metab Rev. 2000; 32: 119–28.
  • Rall DP. Shoe-leather epidemiology-the footpads of mice and rats: animal tests in assessment of occupational risks. Mt Sinai J Med. 1994; 61: 504–8.
  • Huff J. Chemicals studied and evaluated in long-term carcino-genesis bioassays by both the Ramazzini Foundation and the National Toxicology Program: in tribute to Cesare Maltoni and David Rall. Ann NYAcad Sci. 2002; 982: 208–30.
  • Huff J. Chemicals causally associated with cancers in humans and in laboratory animals: a perfect concordance. Chapter 2: 25-37. In: Waalkes MP, Ward JM (eds). Carcinogenesis. New York: Raven Press, 1994.
  • Tomatis L, HuffJ, Hertz-Picciotto I, et al. Avoided and avoidable risks of cancer. Carcinogenesis. 1997; 18: 97–105.
  • Maltoni C, Soffritti M, Belpoggi E The scientific and method-ological bases of experimental studies for detecting and quanti-fying carcinogenic risks. Ann NYAcad Sci. 1999; 895: 10–26.
  • Huff J. Long-term chemical carcinogenesis bioassays predict human cancer hazards. Issues, controversies, and uncertainties. Ann NYAcad Sci. 1999; 895: 56–79.
  • Tomatis L, Melnick RL, Haseman J, Barrett JC, Huff J. Alleged misconceptions distort perceptions of environmental cancer risks. FASEB J. 2001; 15: 195–203.
  • Haseman J, Melnick R, Tomatis L, HuffJ. Carcinogenesis bioas-says: study duration and biological relevance. Food Chem TOXi-col. 2001; 39: 739–44.
  • Maronpot RR, Flake G, Huff J, Relevance of animal carcinogen-esis findings to human cancer predictions and prevention. Tox-icol Pathol. 2004;32 suppl 1: 40-8.
  • Dunnick JK, Hailey JR. Phenolphthalein exposure causes multiple carcinogenic effects in experimental model systems. Cancer Res. 1996; 56: 4922–6.
  • Huff J, Melnick R. What are the real causes of cancer? Int J Occup Environ Health. 2006; 12: 81–6.
  • Tomatis L, Huff J. Evolution of research on cancer etiology. Chapter 9: 189-201. In: Coleman WB, Tsongalis GJ (eds). The Molecular Basis of Human Cancer: Genomic Instability and Molecular Mutation in Neoplastic Transformation. Totowa, NJ: Humana Press, 2002.
  • China aspartame. http://www.alibaba.com/countrysearch/cn-suppliers/aspartame.html.
  • China aspartame manufacturers. http://www.made-in-china.com/china-products/productviewvfgecarlqmiw/aspartame.html.
  • Lim U, Subar AF, Mouw T., et al Consumption of aspartame-containing beverages and incidence of hematopoietic and brain malignancies. Cancer Epidemiol Biomarkers Prey. 2006; 15: 1654–9.
  • Gallus S, Scotti L, Negri E., et al Artificial sweeteners and cancer risk in a network of case-control studies. Ann Oncol. 2007; 18: 40–4.
  • Huff J, Castleman B, LaDou J., et al, Primary prevention of cancer. The Scientist. 2002 Sep 16; 16 (18): 10–11.
  • FDA. Aspartame: Commissioners Final Decision. Fed Reg. 1981 July 24;46[142] :38235-308.
  • Congress. GAO Investigating NutraSweet approval. UPI, reprinted in Congressional Record, August 1, 1985, p S10823.
  • Gordon G. NutraSweet: questions swirl. UPI Investigative Report, 10/12/87. Reprinted in U.S. Senate, 1987, pp 483-510.
  • Gordon G. FDA resisted proposals to test aspartame for years. Star Tribune. 22 Nov 1996.
  • Jacobson M, HuffJ. Are 2-year exposure regimens optimum for identifying chemical carcinogens? Environ Health Perspect. 2007 [submitted] Related Reading
  • History of aspartame. !http://www.dorway.com/enclosur.html.

Related Reading

  • Preapproval “research” & history of aspartame. http://www.holisticmed.com/aspartame/history.faq.
  • Granitic Believers, http://presidiotex.com/nutrapoison/believers.html.
  • The Good Stuff. http://presidiotex.com/nutrapoison/stuff.html.
  • Donald Rumsfeld and aspartame. http://www.newswithviews.com/nwvexclusive/exclusive15.htm.
  • Connection between Donald Rumsfeld and Dr. Arthur Hayes. http://www.politicalfriendster.com/showconnection.php?idl=568cid2=2770.
  • Aspartame Warning. http://www.321recipes.com/aspartame.html.
  • Abdo KM, Camargo CA Jr, Davis D., et al Letter to U.S. FDA Commissioner. Int J Occup Environ Health. 2007; 13: 453–4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.